Takeda to pull lung cancer med Exkivity around the world after confirmatory trial flop
Fierce Pharma
OCTOBER 3, 2023
Takeda is plotting voluntary withdrawals of Exkivity around the world, too. . | Takeda will work with the FDA to chart a voluntary withdrawal of Exkivity in the U.S., where the drug is approved for certain adult lung cancer patients whose disease has progressed on or after platinum-based chemotherapy.
Let's personalize your content